SCHEMBL4702045

SCHEMBL4702045

CCOC(=O)N1CCC(O)(c2ccccc2Oc2ccc(F)cc2C)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
APP P05067 6/20 0.46
LMNA P02545 2/20 0.46
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
PDK2 Q15119 1/20 0.43
ALDH1A1 P00352 4/20 0.42
TSHR P16473 2/20 0.42
MAPT P10636 2/20 0.41
OPRD1 P41143 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
CASP1 P29466 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4702916 0.90 L3MBTL1 (0.57) L3MBTL1APPLMNAPSEN1PSEN2
SCHEMBL6002487 0.88 OPRM1 (0.40) L3MBTL1OPRD1
SCHEMBL4701060 0.88 PDK2 (0.43) L3MBTL1PDK2TSHR
SCHEMBL4702942 0.86 APP (0.44) L3MBTL1APPPSEN1PSEN2APH1B
SCHEMBL4700627 0.86 L3MBTL1 (0.53) L3MBTL1APPLMNAPSEN1PSEN2
SCHEMBL3546367 0.81 L3MBTL1 (0.58) L3MBTL1APPLMNAPSEN1PSEN2
SCHEMBL9528495 0.81 APP (0.66) L3MBTL1APPPSEN1PSEN2APH1B
SCHEMBL4703685 0.80 L3MBTL1 (0.54) L3MBTL1APPLMNAPSEN1PSEN2
SCHEMBL4702948 0.78 APP (0.57) L3MBTL1APPPSEN1PSEN2APH1B
SCHEMBL4789410 0.78 HTR1A (0.42) L3MBTL1PDK2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635828-B1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS LUNDBECK & CO AS H (DK) 2008-04-23 EP disclosed
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors H. LUNDBECK A/S (DK) 2006-12-28 US disclosed
EP-1635828-A1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. Lundbeck A/S (DK) 2006-03-22 EP disclosed
WO-2004087155-A1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. LUNDBECK A/S (DK) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors HTR1D, TPH1, HTR2C L3MBTL1 4442/4885APP 1306/4885LMNA 4523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.